Book section Open Access

# Atlas of Cancer Signaling Network: A resource of multi-scale biological maps to study disease mechanisms

L Cristobal Monraz Gomez; Maria Kondratova; Nicolas Sompairac; Christine Lonjou; Jean-Marie Ravel; Emmanuel Barillot; Andrei Zinovyev; Inna Kuperstein

### Citation Style Language JSON Export

{
"publisher": "Elsevier",
"DOI": "10.1016/B978-0-12-801238-3.11683-6",
"container_title": "Systems Medicine: Integrative Qualitative and Computational Approaches",
"title": "Atlas of Cancer Signaling Network: A resource of multi-scale biological maps to study disease mechanisms",
"issued": {
"date-parts": [
[
2020,
6,
1
]
]
},
"abstract": "<p>ACSN (https://acsn.curie.fr) is a web-based resource of multi-scale biological maps depicting molecular processes in cancer cell and tumor microenvironment. The core of the Atlas is a set of interconnected cancer-related signaling and metabolic network maps. Molecular mechanisms are depicted on the maps at the level of biochemical interactions, forming a large seamless network. The Atlas is a &quot;geographic-like&quot; interactive &quot;world map&quot; of molecular interactions leading the hallmarks of cancer as described by Hanahan and Weinberg. The Atlas is created using the systems biology standards and therefore is amenable for computational analysis. The maps of ACSN are organized in a hierarchical manner and decomposed into functional modules with meaningful network layout. Navigation of the ACSN is intuitive thanks to the Google Maps-like features in the NaviCell web platform. Particularly, the exploration of the Atlas is simplified due to the semantic zooming feature, allowing the user to visualize the seamless Atlas and individual maps from the collection at different levels of details. The resource includes tools for visualization and analysis of molecular data in the context of signaling network maps. In this chapter we present how a disease-specific resource such as the<br>\nAtlas of Cancer Signaling Network (ACSN) can be useful to study and interpret molecular perturbations in cancer, among others, explaining drug resistance, suggesting intervention points, finding phenotype shifts through disease progression, explaining susceptibility to a particular type of cancer and studying disease comorbidities.</p>",
"author": [
{
"family": "L Cristobal Monraz Gomez"
},
{
"family": "Maria Kondratova"
},
{
"family": "Nicolas Sompairac"
},
{
"family": "Christine Lonjou"
},
{
"family": "Jean-Marie Ravel"
},
{
"family": "Emmanuel Barillot"
},
{
"family": "Andrei Zinovyev"
},
{
"family": "Inna Kuperstein"
}
],
"note": "This is an author (before editorial process) version of the published chapter 10.1016/B978-0-12-801238-3.11683-6",
"type": "chapter",
"id": "3896747"
}
39
47
views